Has Carlos Rodriguez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $13,624 in general payments to Carlos Rodriguez, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Carlos Rodriguez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Carlos Rodriguez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Carlos Rodriguez, MD

Cardiovascular Disease · Winston Salem, NCNPI 1023192820

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Amgen accounts for 72.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $7,737 and has fallen 66.3% since, to $2,607 in 2025.

$13,624in general payments, 2019–2025

Across 22 payments — averaging $619.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$10K
Merck$3K
Stryker$284
AstraZeneca$212
Revance Therapeutics, Inc.$37
Lantheus Medical Imaging, Inc.$33
plus $114 from 6 others

$532,503in research payments, 2019–2025

Across 7 payments — averaging $76,072 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Amgen$533K

What the payments were for

Consulting fees$2,26217%
Speaking & faculty fees$3,00022%
Travel & lodging$7,47755%
Food & beverage$8856%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	7	$9,909
Merck	2	$3,035
Stryker	2	$284
AstraZeneca	2	$212
Revance Therapeutics, Inc.	1	$37
Lantheus Medical Imaging, Inc.	2	$33
AbbVie	1	$30
Melinta Therapeutics, LLC	1	$24
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$22
Genentech USA, Inc.	1	$16
Alnylam Pharmaceuticals Inc.	1	$11
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,624 in reported general payments places this provider in the 85th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina →

Medicare billing

Part B allowed, 2024

$7,566

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	63	$40,661
JardianceEmpagliflozin	14	$14,151
XareltoRivaroxaban	13	$6,867
VascepaIcosapent Ethyl	17	$4,863
Metoprolol Succinate	128	$1,350
Valsartan	47	$732
Rosuvastatin Calcium	44	$488
Atorvastatin Calcium	60	$485
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide	24	$421
Ezetimibe	18	$400
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide	21	$350
Nifedipine ErNifedipine	30	$346
Losartan Potassium	48	$303
Pravastatin Sodium	19	$301
Carvedilol	44	$279

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Winston Salem

Dalane KitzmanWinston Salem$199K
George BodziockWinston Salem$54K
Patrick KozakWinston Salem$44K
R WilliamsDurham$2.1M
Marat FudimDurham$902K
Jonathan PicciniDurham$767K
Michael RinaldiCharlotte$722K
Markus SchererCharlotte$526K
Robert MentzDurham$489K
Sean PokorneyMorganton$477K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →